Results Of A Phase I Pharmacokinetic Study Of Intraperitoneal Bortezomib (B) And Carboplatin (C) In Patients With Persistent Or Recurrent Ovarian Cancer (Oc): An Nrg/Gynecologic Oncology Group Study.
JOURNAL OF CLINICAL ONCOLOGY(2015)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要